Bristol-Myers Squibb Company (BCBA:BMY)

Argentina flag Argentina · Delayed Price · Currency is ARS
27,580
+100 (0.36%)
Last updated: Jan 21, 2026, 11:25 AM BRT
23.54%
Market Cap158.32T
Revenue (ttm)65.83T
Net Income (ttm)8.28T
Shares Outn/a
EPS (ttm)4,071.05
PE Ratio19.13
Forward PE9.13
Dividend792.03 (2.83%)
Ex-Dividend DateJan 2, 2026
Volumen/a
Average Volume789
Open27,580
Previous Close27,480
Day's Range27,580 - 27,580
52-Week Range16,950 - 29,400
Betan/a
RSI50.56
Earnings DateFeb 5, 2026

About BCBA:BMY

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Industry Pharmaceutical Preparations
Founded 1887
Employees 34,100
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol BMY
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements